期刊文献+

大肠癌患者组织多项基质金属蛋白、VEGF-C、VEGF-D、Ets-1、CD44v6及VEGFR-3的变化 被引量:11

Change of tissue multiple matrix metalloproteinase,VEGF-C,VEGF-D,Ets-1,CD44v6 and VEGFR-3 of patients with colorectal cancer
下载PDF
导出
摘要 目的:探讨大肠癌患者组织多项基质金属蛋白、血管内皮生长因子(VEGF)一C、VEGF—D、Ets一1、CD44v6及血管内皮生长因子受体一3(VEGFR一3)的变化情况。方法:选取2010年1月2012年9月于本院进行诊治的35例大肠癌患者为观察组,同期进行检查诊断的35例大肠良性病变患者为对照组,比较两组患者组织的基质金属蛋白酶(MMP)一1、MMP一2、MMP一3、MMP一7及VEGF—C、VEGF—D、Ets一1、CD44v6、VEGFR一3阳性表达率,并比较不同分期及有无转移观察纽的上述指标阳性率。结果:观察纽MMP一1、MMP一2、MMP一3、MMP一7及VEGF—C、VEGF—D、Ets一1、CD44v6、VEGFR一3阳性表达率均高于对照组,且观察组中Duke's分期较高者及有转移者的上述指标阳性率高于Duke’S分期较低者及无转移者,差异均有统计学意义(P均〈0.05)。结论:大肠癌患者组织多项基质金属蛋白、VEGF—C、VEGF-D、Ets一1、CD44v6及VEGFR一3的阳性表达率均较高,且不同Duke’S分期及有无转移者之间也存在差异。 Objective. To study the change of tissue multiple matrix metalloproteinase,VEGF-C, VEGF-D,Ets-l,CD44v6 and VEGFR-3 of patients with colorectal cancer. Methods. A total of 35 patients with colorectal cancer who were diagnosed and treated in our hospital from January 2010 to September 2012 were selected as observation group, then the positive expression rate of tissue MMP-1, MMP-2, MMP- 3 ,MMP-7 and VEGF-C, VEGF-D, Ets-1, CD44v6, VEGFR-3 of two groups were analyzed and compared,
出处 《海南医学院学报》 CAS 2014年第2期177-179,183,共4页 Journal of Hainan Medical University
基金 湖南省自然科学基金资助项目(02817234)~~
关键词 大肠癌基质金属蛋白 血管内皮生长因子(VEGF)一C VEGF-D Ets一1 CD44V6 血管内皮生长因子受体一3(VEGFR一3) Colorectal cancer Matrix metalloproteinase VEGF-C VEGF-D Ets-1 CD44v6 VEG-FR-3
  • 相关文献

参考文献11

二级参考文献62

  • 1佟学颖.大肠癌血管内皮生长因子的表达与微血管密度的研究[J].吉林医学,2006,27(3):296-297. 被引量:1
  • 2Karpanen T,Egeblad M,Karkkainen MJ,et al.Vascular endo-thelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.Cancer Res,2001,61(5):1786-1790.
  • 3Karkkainen MJ,Petrova TV.Vascular endothelial growth factor receptors in regulation of angiogenesis and lymphangiogenesis.Oncoene,2000,19(49):5598-5605.
  • 4Hung CJ,Ginzinger DG,Zarneger R,et al.Expression of vas-cular endothelial growth factor C in benign and malignant thyroid tumors.J Clin Endocrinol Meta,2003,88(8):3694-3699.
  • 5Shida A,Fujioka S,Kobayashi K,et al.Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcino-ma.Int J Clin Oncol,2006,11(1):38-43.
  • 6Kawakami M,Furuhata T,Kimura Y,et al.Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer.Surgery,2003,133(3):300-308.
  • 7Van Trappen PO,Steele D,Lowe DG,et al.Expression of vas-cular endothelial growth factor (VEGF)-C and -D and their re-ceptor VEGFR-3,during different stages of cervical carcinogene-sis.J Pathol,2003,201(4):544-549.
  • 8Mylona E,Alexandrou P,Mpakali A,et al.Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast car-cinoma.Eur J Surg Oncol,2007,33(3):294-300.
  • 9Saito H, Tsujitani S, Oka S, et al. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chem- otherapy using fluorouracil derivatives in advanced gastric carcinoma [ J]. Bri J Cancer, 1999,81 (3) :484-489.
  • 10Yang SF, Wang SN, Wu CF, et al. Altered p-STAT3 ( tyr705 ) ex- pression is associated with histological grading and intratumour mi- crovessel density in hepatocellular carcinoma [ J ]. J Clin Pathol, 2007,60(6) :642-648.

共引文献24

同被引文献123

引证文献11

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部